A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib
NCT03008512
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class
Stopped
Poor accrual
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG:
Genexol-PM
Sponsor
Gachon University Gil Medical Center